← Back to Search

Penicillin Antibiotic

B for Acute Bacterial Sinusitis

Phase 3
Waitlist Available
Research Sponsored by Abbott
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 33 days
Awards & highlights

Summary

To compare the safety/tolerability and efficacy of a 14-day course of clarithromycin extended-release tablets (2 x 500 mg QD) with that of a 14-day course of amoxicillin-clavulanate tablets (875/125 mg BID) for the treatment of ambulatory subjects with Acute Bacterial Sinusitis (ABS).

Eligible Conditions
  • Acute Bacterial Sinusitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~33 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 33 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinical Response
Secondary outcome measures
Radiographic Response

Trial Design

2Treatment groups
Active Control
Group I: BActive Control1 Intervention
Group II: AActive Control1 Intervention

Find a Location

Who is running the clinical trial?

AbbottLead Sponsor
752 Previous Clinical Trials
477,928 Total Patients Enrolled
~20 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top